Saturday, June 20, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 824 of 1,261

  1. US 8686045

    Methods of facilitating neural cell survival using non-peptide and peptide BDNF neurotrophin mimetics

    The Regents of the University of California · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  2. US 8686016

    Schweinfurthins and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  3. US 8685403

    Insulin-like growth factor signaling and integrin

    The Regents of the University of California · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  4. US 8685396

    Monoclonal antibodies that neutralize anthrax protective antigen (PA) toxin

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  5. US 8685929

    Detecting CYP24 expression level as a marker for predisposition to cancer

    The Regents of the University of California · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  6. US 8685890

    Multispecific peptides

    BICYCLE THERAPEUTICS LIMITED · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  7. US 8685722

    Bovine adeno-associated viral (BAAV) vector and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  8. US 8685416

    Compositions and methods for the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  9. US 8685411

    Rotavirus antigens

    The United States of America as represented by the Dept. of Health and Human Services (DHHS) · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  10. US 8685734

    Viral purification methods

    ONCOLYTICS BIOTECH INC. · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  11. US 8685538

    Stable polyelectrolyte coated nanoparticles

    Northwestern University · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  12. US 8685406

    Compositions of and method of using heat shock protein peptides

    The Board of Regents of the University of Texas System · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  13. US 8685383

    Protein-polymer-drug conjugates

    Mersana Therapeutics, Inc. · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  14. US 8685372

    Peptides and aptamers for targeting of neuron or nerves

    The Regents of the University of California · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  15. US 8685931

    Hair growth methods using FGFR3 extracellular domains

    Five Prime Therapeutics, Inc. · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  16. US 8685917

    Cyclosporin analogues

    Enanta Pharmaceuticals, Inc. · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  17. US 8680291

    Diarylhydantoin compounds

    The Regents of the University of California · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  18. US 8680263

    Carbohydrate-based drug delivery polymers and conjugates thereof

    Nektar Therapeutics · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  19. US 8680150

    Small molecule hematopoietic growth factor mimetic compounds that activate hematopoietic growth factor receptors

    Ligand Pharmaceuticals Incorporated · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  20. US 8680083

    Controlled release corticosteroid compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  21. US 8680094

    1, 4-benzoxazine compounds and derivatives thereof as therapeutic drugs for the treatment of neurodegenerative conditions

    The Board of Regents of the University of Texas System · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  22. US 8680132

    Spiro-oxindole MDM2 antagonists

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  23. US 8680319

    Method for producing antifolate agents having glutamic acid part in their structure

    Kocak Farma Ilac ve Kimya Sanayi A.S. · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  24. US 8680113

    BMI-1 protein expression modulators

    PTC THERAPEUTICS, INC. · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.